Search results
Results from the WOW.Com Content Network
Cutaneous dysesthesia is characterized by discomfort or pain from touch to the skin by normal stimuli, including clothing. The unpleasantness can range from a mild tingling to blunt, incapacitating pain. [citation needed] Scalp dysesthesia is characterized by pain or burning sensations on or under the surface of the cranial skin. Scalp ...
Allodynia is a clinical feature of many painful conditions, such as neuropathies, [4] complex regional pain syndrome, postherpetic neuralgia, fibromyalgia, and migraine. Allodynia may also be caused by some populations of stem cells used to treat nerve damage including spinal cord injury .
The intensity of pain reported is consistently reduced in response to touch. [5] [6] [7] This occurs whether the touch is at the same time as the pain, or even if the touch occurs before the pain. [8] Touch also reduces the activation of cortical areas that respond to painful stimuli. [9]
Eczema is a skin condition marked by intense redness, itching, and cracked skin. One woman found relief using a combination of prescriptions and cosmetic products. 31 Million Americans Deal With ...
Amplified musculoskeletal pain syndrome (AMPS) is an illness characterized by notable pain intensity without an identifiable physical cause. [1] [6] Characteristic symptoms include skin sensitivity to light touch, also known as allodynia. Associated symptoms may include changes associated with disuse including changes in skin texture, color ...
It is occasionally accompanied by pain, paresthesia (pins and needles), or hyperesthesia (unusual or pathologically increased sensitivity of the skin to sensory stimuli, such as pain, heat, cold, or touch), which results in a well circumscribed hyperpigmentation of a skin patch in the affected area.
Pyoderma gangrenosum is a rare, inflammatory skin disease where painful pustules or nodules become ulcers that progressively grow. [3] Pyoderma gangrenosum is not infectious. [3] Treatments may include corticosteroids, ciclosporin, infliximab, or canakinumab. [2] The disease was identified in 1930.
Cutaneous receptors are at the ends of afferent neurons. works within the capsule. Ion channels are situated near these networks. In sensory transduction, the afferent nerves transmit through a series of synapses in the central nervous system, first in the spinal cord, the ventrobasal portion of the thalamus, and then on to the somatosensory cortex.